Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesothelin Expressing Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03816358
What this trial is testing

Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 74
Early research (Phase 1)UnknownNCT05089266
What this trial is testing

Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors

Who this might be right for
Colorectal Cancer
Shanghai Cell Therapy Group Co.,Ltd 30
Testing effectiveness (Phase 2)UnknownNCT03615313
What this trial is testing

PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Shanghai Cell Therapy Research Institute 50
Early research (Phase 1)Study completedNCT02824042
What this trial is testing

Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Who this might be right for
Medical Oncology
Bayer 63
Testing effectiveness (Phase 2)UnknownNCT05944185
What this trial is testing

Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai Cell Therapy Group Co.,Ltd 42
Early research (Phase 1)WithdrawnNCT05375825
What this trial is testing

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Who this might be right for
Malignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02839681
What this trial is testing

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

Who this might be right for
Lung Neoplasms
National Cancer Institute (NCI) 2
Early research (Phase 1)Ended earlyNCT05164666
What this trial is testing

TAK-103 in Adult With Solid Tumors

Who this might be right for
Solid Tumors
Takeda 2
Early research (Phase 1)Active Not RecruitingNCT02792114
What this trial is testing

T-Cell Therapy for Advanced Breast Cancer

Who this might be right for
Breast CancerMetastatic HER2-negative Breast
Memorial Sloan Kettering Cancer Center 186
Early research (Phase 1)UnknownNCT02930993
What this trial is testing

Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors

Who this might be right for
Mesothelin Positive Tumors
China Meitan General Hospital 20
Early research (Phase 1)Looking for participantsNCT06760364
What this trial is testing

A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancers
Tianjin Medical University Cancer Institute and Hospital 21
Testing effectiveness (Phase 2)UnknownNCT03182803
What this trial is testing

CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Shanghai Cell Therapy Research Institute 40
Early research (Phase 1)Study completedNCT02696642
What this trial is testing

Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

Who this might be right for
Neoplasms
Bayer 54
Early research (Phase 1)UnknownNCT05775666
What this trial is testing

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
Peking University 87
Early research (Phase 1)Study completedNCT03054298
What this trial is testing

CAR T Cells in Mesothelin Expressing Cancers

Who this might be right for
Lung AdenocarcinomaOvarian CancerPeritoneal Carcinoma+3 more
University of Pennsylvania 65
Not applicableStudy completedNCT05372692
What this trial is testing

Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Weijia Fang, MD 3
Early research (Phase 1)UnknownNCT05848999
What this trial is testing

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Mesothelin-positive Advanced Malignant Solid Tumors
Zhejiang University 87
Early research (Phase 1)UnknownNCT03747965
What this trial is testing

Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid Tumors

Who this might be right for
Solid Tumor, Adult
Chinese PLA General Hospital 10
Early research (Phase 1)Study completedNCT02159716
What this trial is testing

CART-meso in Mesothelin Expressing Cancers

Who this might be right for
Metastatic Pancreatic (Ductal) AdenocarcinomaEpithelial Ovarian CancerMalignant Epithelial Pleural Mesothelioma
University of Pennsylvania 19
Early research (Phase 1)Looking for participantsNCT06885697
What this trial is testing

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Who this might be right for
MesotheliomaNeoplasmsStomach Neoplasms+5 more
National Cancer Institute (NCI) 100
Next Page